Addex Therapeutics (ADXN) Total Current Liabilities (2018 - 2026)
Addex Therapeutics (ADXN) posted Total Current Liabilities of $1.6 million for Q1 2026, up 4.04% sequentially from $1.5 million in Q4 2025, and up 32.78% YoY from $1.2 million in Q1 2025.
Addex Therapeutics (ADXN) Total Current Liabilities (2018 - 2026) Analysis & Trends
Addex Therapeutics has reported Total Current Liabilities for 9 years, with the latest figure at $1.6 million in Q1 2026.
- Quarterly Total Current Liabilities rose 32.78% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (up 32.78% YoY) and the FY2025 annual result came in at $1.4 million, up 58.61% from the prior year.
- Total Current Liabilities rose to $1.6 million in Q1 2026 per ADXN's latest filing, from $1.5 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $5.3 million in Q1 2024 and troughed at $915606.7 in Q4 2024.
- A 5-year average of $2.6 million and a median of $2.2 million in 2023 frame the typical range for Total Current Liabilities.
- The widest YoY moves for Total Current Liabilities: up 63.84% in 2025, down 77.96% in 2025.
- Over 5 years, Total Current Liabilities stood at $3.4 million in 2022, then declined by 4.26% to $3.3 million in 2023, then tumbled by 71.93% to $915606.7 in 2024, then soared by 63.84% to $1.5 million in 2025, then rose by 4.04% to $1.6 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $1.6 million, $1.5 million, and $1.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.51 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 2.49 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 438.74 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 630.93 Mn |
| 10 | Addex Therapeutics | 534.71 Mn | 534.71 Mn | - | 1.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.56 Mn |
| Dec 31, 2025 | 1.50 Mn |
| Sep 30, 2025 | 1.47 Mn |
| Jun 30, 2025 | 1.39 Mn |
| Mar 31, 2025 | 1.18 Mn |
| Dec 31, 2024 | 915,606.68 |
| Sep 30, 2024 | 1.02 Mn |
| Jun 30, 2024 | 1.04 Mn |
| Mar 31, 2024 | 5.33 Mn |
| Dec 31, 2023 | 3.26 Mn |
| Sep 30, 2023 | 2.19 Mn |
| Jun 30, 2023 | 3.02 Mn |
| Mar 31, 2023 | 3.45 Mn |
| Dec 31, 2022 | 3.41 Mn |
| Sep 30, 2022 | 4.28 Mn |
| Jun 30, 2022 | 4.46 Mn |
| Mar 31, 2022 | 4.30 Mn |
| Dec 31, 2021 | 4.48 Mn |
| Sep 30, 2021 | 3.56 Mn |
| Jun 30, 2021 | 4.04 Mn |